Results 121 to 130 of about 16,531 (215)

Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients

open access: yesFrontiers in Immunology, 2018
Background: Bullous pemphigoid is a subepidermal blistering skin disease, associated with autoantibodies to hemidesmosomal proteins, complement activation at the dermal-epidermal junction, and dermal granulocyte infiltration.
Roxana M. Chiorean   +9 more
doaj   +1 more source

Bullous Pemphigoid [PDF]

open access: yesJournal of General Internal Medicine, 2012
Barry, Ladizinski, Kachiu Cecelia, Lee
openaire   +2 more sources

Rituximab for the Management of an Australian Cohort of Treatment Refractory Mucous Membrane Pemphigoid

open access: yesAustralasian Journal of Dermatology, Volume 66, Issue 5, Page e271-e278, August 2025.
ABSTRACT Background Mucous membrane pemphigoid (MMP) has a broad range of clinical manifestations, from relatively benign self‐limiting oral lesions to significant scarring (cicatrizing) of the oral, nasal and ocular tissues with severe functional impairment and morbidity.
Bronte Jeffrey   +9 more
wiley   +1 more source

Bullous Pemphigoid [PDF]

open access: yesJAMA Dermatology, 2013
Misha, Rosenbach   +2 more
openaire   +2 more sources

The 'Spectraplakins': cytoskeletal giants with characteristics of both spectrin and plakin families [PDF]

open access: yes, 2002
Recent studies have characterised a family of giant cytoskeletal crosslinkers encoded by the short stop gene in Drosophila and the dystonin/BPAG1 and MACF1 genes in mammals.
Brown, N., Gregory, S., Roeper, K.
core   +2 more sources

Pemphigoid gestationis and intravenous immunoglobulin therapy

open access: yesInternational Journal of Women's Dermatology, 2018
Pemphigoid gestationis, which is also known as herpes gestationis, is a rare, pregnancy-associated, autoimmune bullous disease. Treatment depends on the severity of the disease for each patient and the safety and use of these drugs during pregnancy and ...
Anes Yang, MD, BMed, MPH   +2 more
doaj  

Dental Implant Therapy in Patients With Autoimmune Diseases: A Scoping Review

open access: yesClinical Oral Implants Research, Volume 36, Issue 8, Page 913-929, August 2025.
ABSTRACT Objectives The aim of this scoping review is to determine the effects of autoimmune diseases (ADs) and the agents used for treatment on dental implant survival and biologic outcomes. Material and Methods An electronic database search was performed in MEDLINE (PubMed), The Cochrane Library, and Embase on 29‐04‐2024.
Emil Hyldahl   +2 more
wiley   +1 more source

Pemphigoid: Bullous and Cicatricial

open access: yesDermatologic Clinics, 1990
Bullous pemphigoid is a blistering disease of the elderly that often is self-limited. It is apparently caused by autoantibodies against antigens of the basal cell hemidesmosome. There is apparently more than one antigen, but the most significant has a molecular weight of about 230 kD and the second most frequently detected antigen has a lower molecular
openaire   +3 more sources

Sensitivity of direct immunofluorescence in oral diseases : study of 125 cases [PDF]

open access: yes, 2008
Direct immunofluorescence (DIF) is widely used for the diagnosis of bullous diseases and other autoimmune pathologies such as oral lichen planus. There is no evidence in the literature on how the following variants influence the detection rate of DIF ...
Aguas, Silvia Cristina   +6 more
core  

Bullous pemphigoid induced by the dipeptidyl-peptidase IV inhibitors (gliptins) [PDF]

open access: yes, 2014
Background Bullous pemphigoid (BP) is the most frequent autoimmune blistering dermatosis. Recently, the development of BP in patients treated with gliptins, also known as DPP-4 inhibitors, alone or in association with metformin has been outlined in case ...
SCHAFFER, C.
core  

Home - About - Disclaimer - Privacy